Product Information
FUROSEMIDE 20 MG/2 ML VIAL is a generic product labeled by Devatis Inc., priced at $0.4616 per ML under NDC 73043002201. Its NADAC has been published 33 times since Jan 7, 2026.
FDA first approved this application on Apr 2, 2024. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Devatis Inc.NDC
73043002201
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
FUROSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215856FDA Approved
4/2/2024
TE Code
AP
On Market Since
8/10/2024
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 20 MG/2 ML VIAL has been published 33 times since Jan 7, 2026, and over the history we have for it it has risen 32.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4616 per ML |
|---|---|
| All-time high | $0.4616 (Aug 19, 2026) |
| All-time low | $0.3473 (Jan 7, 2026) |
| 52-week high | $0.4616 |
| 52-week low | $0.3473 |
| Median price | $0.4049 |
| Average price | $0.3989 |
| Largest weekly change | +7.6% (Mar 18, 2026) |
| Weeks tracked | 33 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FUROSEMIDE 20 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 20 MG/2 ML VIAL, manufactured by Devatis Inc., is $0.4616 per ML (NDC 73043002201), effective Aug 19, 2026.
How has the price of FUROSEMIDE 20 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has risen 32.9%. It has been tracked across 33 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 20 MG/2 ML VIAL?
Since Jan 7, 2026, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has ranged from a low of $0.3473 (Jan 7, 2026) to a high of $0.4616 (Aug 19, 2026), with a median of $0.4049 per ML.
Are there cheaper alternatives to FUROSEMIDE 20 MG/2 ML VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FUROSEMIDE 40 MG/4 ML VIAL, is $0.2334 per ML — about 49% below FUROSEMIDE 20 MG/2 ML VIAL.
Who manufactures FUROSEMIDE 20 MG/2 ML VIAL?
FUROSEMIDE 20 MG/2 ML VIAL (NDC 73043002201) is labeled by Devatis Inc., and CMS classifies it as a generic product.